Regular Article
How does one assess early rheumatoid arthritis in daily clinical practice?

https://doi.org/10.1053/berh.2000.0126Get rights and content

Abstract

In past years, consensus has been reached on the assessment of rheumatoid arthritis in clinical trials. Next to a core set of disease activity variables, response criteria have been developed and validated. These criteria are, however, of limited value in daily clinical practice. In this situation, emphasis should be paid to accurate measurement of disease activity on a continuous scale using the lowest possible number of core set variables. Different studies have shown that the DAS28 is a valuable instrument for this purpose. Many factors have been identified to possess a prognostic value; however, the IgM rheumatoid factor is still the only one which is of any importance in daily clinical practice.

References (62)

  • P LCM van Riel et al.

    Clinical assessment and clinical trials in rheumatoid arthritis

    Current Opinion in Rheumatology

    (1994)
  • P LCM van Riel

    Provisional guidelines for measuring disease activity in clinical trials on rheumatoid arthritis

    British Journal of Rheumatology

    (1992)
  • DT Felson et al.

    The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials

    Arthritis and Rheumatism

    (1993)
  • DE Furst et al.

    Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis

    Journal of Rheumatology

    (1989)
  • P LCM van Riel et al.

    Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis

    British Journal of Rheumatology

    (1995)
  • V Mladenovic et al.

    Safety and effectiveness of leflunomide in the treatment of patients with rheumatoid arthritis

    Arthritis and Rheumatism

    (1995)
  • MJ Elliot et al.

    Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

    Lancet

    (1994)
  • LW Moreland et al.

    Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

    New England Journal of Medicine

    (1997)
  • YS Sherrer et al.

    The development of disability in rheumatoid arthritis

    Arthritis and Rheumatism

    (1986)
  • D Van Zeben et al.

    Factors predicting outcome of rheumatoid arthritis: results of a followup study

    Journal of Rheumatology

    (1993)
  • BJ Harrison et al.

    Inflammatory polyarthritis in the community is not a benign disease: predicting functional disability one year after presentation

    Journal of Rheumatology

    (1996)
  • A Fleming et al.

    Prognostic values of early features in rheumatoid disease

    British Journal of Rheumatology

    (1993)
  • M Corbett et al.

    Factors predicting death, survival, and functional status in a prospective study of rheumatoid disease over fifteen years of disease

    British Journal of Rheumatology

    (1993)
  • F Wolfe et al.

    The assessment and prediction of functional disability in rheumatoid arthritis

    Journal of Rheumatology

    (1991)
  • D MFM van der Heijde et al.

    Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective followup study of 147 patients

    British Journal of Rheumatology

    (1992)
  • KB Eberhardt et al.

    Early rheumatoid arthritis onset, course and outcome over 2 years

    Rheumatology International

    (1990)
  • N Graudal et al.

    Inflammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate and hemoglobin. Long term course and association to radiographic progression

    Journal of Rheumatology

    (2000)
  • Mottonen, T, T, Prediction of erosiveness and rates of development of new erosions in early rheumatoid...
  • AR Gough et al.

    Genetic typing of patients with inflammatory arthritis at presentation is predictive of outcome

    Arthritis and Rheumatism

    (1994)
  • CM Weyand et al.

    The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis

    Annals of Internal Medicine

    (1992)
  • CM Weyand et al.

    Homozygosity for the HLA-DRB1 allele selects for extra-articular manifestation in rheumatoid arthritis

    Journal of Clinical Investigation

    (1992)
  • AJ Silman et al.

    HLA-DR4 as a predictor of outcome three years after onset of rheumatoid arthritis

    Rheumatology International

    (1986)
  • L Paimela et al.

    The prognostic value of HLA-DR4 and B27 antigens in early rheumatoid arthritis

    Scandinavian Journal of Rheumatology

    (1993)
  • E JA Kroot et al.

    The prognostic value of the antiperinuclear factor, determined by a recently developed peptide-based ELISA, using anti citrulline-containing peptide antibodies (anti-CCP) in patients with recent-onset rheumatoid arthritis

    Arthritis and Rheumatism

    (2000)
  • JR O'Dell et al.

    HLA-DRB1 typing in rheumatoid arthritis: predicting response to specific treatments

    Annals of the Rheumatic Diseases

    (1998)
  • D Van Zeben et al.

    Factors predicting outcome of rheumatoid arthritis: results of a followup study

    Journal of Rheumatology

    (1993)
  • AD Woolf et al.

    Predictors of the longterm outcome of early synovitis: a five year follow-up study

    British Journal of Rheumatology

    (1991)
  • K Eberhardt et al.

    HLA-DR antigens, GM allotypes, and anti-allotypes in early rheumatoid arthritis—their relation to disease progression

    Journal of Rheumatology

    (1993)
  • A Mustila et al.

    Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis

    Arthritis and Rheumatism

    (2000)
  • G Hayem et al.

    Anti SA antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis

    Journal of Rheumatology

    (1999)

    • Cited by (63)

    View all citing articles on Scopus
    View full text
    Copyright © 2001 Harcourt Publishers Ltd. All rights reserved.